Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2571-2576.
Prepublished online as a Blood First Edition Paper on November 13, 2003; DOI 10.1182/blood-2003-07-2316.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-07-2316v1
103/7/2571    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lefebvre, P.
Right arrow Articles by Lorand, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefebvre, P.
Right arrow Articles by Lorand, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted July 11, 2003
Accepted October 28, 2003

Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen A{alpha}IVS4+1 G>T mutation and an A{alpha}Gln328 truncation (Fibrinogen Keokuk)

Phil Lefebvre, Pauline T Velasco, Amy Dear, Karim C Lounes, Susan T Lord, Stephan O Brennan, David Green*, and Laszlo Lorand

Department of Cell and Molecular Biology, Northwestern University, Chicago, IL, USA
Department of Medicine, Northwestern University, Chicago, IL, USA
Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA

* Corresponding author; email: d-green{at}northwestern.edu.

Two hypofibrinogenemic siblings have lifelong trauma-related bleeding. Recently, the brother suffered recurrent thrombosis after cryoprecipitate infusions post-surgery; the sister has suffered six miscarriages. Their plasma clots were resistant to compression and fibrinolysis, and soluble in 5M urea. Examination by SDS-PAGE revealed only the presence of crosslinked {gamma}-{gamma} fibrin chain dimers without high polymers of {alpha}n. Fibrin clots contained an abnormal 35 kDa constituent recognized by an antibody to fibrinogen A{alpha} chain residues 241-476 but not by antibodies to A{alpha}291-348 or A{alpha}349-406. DNA analysis revealed a heterozygous CAA{Rightarrow}TAA mutation at codon 328 of the A{alpha} gene in these siblings and 2 asymptomatic family members. The Gln328stop mutation (Fibrinogen Keokuk) predicted a 46% truncation and the production of a 35 kDa A{alpha} chain. Analysis of purified fibrinogen revealed expression of the abnormal A{alpha} chain in the 4 family members, but found no normal fibrinogen in the 2 hypofibrinogenemic patients. This paradox was resolved when they, and their asymptomatic mother, were found to be heterozygous for a second A{alpha} mutation, a GT{Rightarrow}TT splice site mutation in intron 4 (IVS4+1 G>T). However, compound heterozygosity for both mutations was required for the expression of severe hypodysfibrinogenemia and clinical symptoms.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. Uitte de Willige, K. F. Standeven, H. Philippou, and R. A. S. Ariens
The pleiotropic role of the fibrinogen {gamma}' chain in hemostasis
Blood, November 5, 2009; 114(19): 3994 - 4001.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
S. O. Brennan, R. L. Davis, R. Lowen, and A. Ruskova
Deletion of five residues from the coiled coil of fibrinogen (B{beta} Asn167_Glu171del) associated with bleeding and hypodysfibrinogenemia
Haematologica, April 1, 2009; 94(4): 585 - 588.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Lorand
Crosslinks in blood: transglutaminase and beyond
FASEB J, June 1, 2007; 21(8): 1627 - 1632.
[Full Text] [PDF]


Home page
BloodHome page
R. Park, H.-J. Doh, S.-S. A. An, J.-R. Choi, K.-H. Chung, and K.-S. Song
A novel fibrinogen variant (fibrinogen Seoul II; A{alpha}Gln328Pro) characterized by impaired fibrin {alpha}-chain cross-linking
Blood, September 15, 2006; 108(6): 1919 - 1924.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
K. S. Song, N. J. Park, J. R. Choi, H. J. Doh, and K. H. Chung
Fibrinogen Seoul (FGG Ala341Asp): A Novel Mutation Associated With Hypodysfibrinogenemia
Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 338 - 343.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020